Follow

Biosergen AS

Nasdaq First North GM Stockholm (Sweden)

Biosergen is a biotech company developing innovative antifungal drugs based on latest biopharmaceutical research and development from laboratory facilities in Trondheim, Norway and several other places worldwide.
Go to market

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
BIOSGN
SE0016013460
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Biosergen AS with ticker BIOSGN
Status
Active
Amount of instruments
28 101 775
Currency
SEK
First trading date
24 Jun 2021
Exercise
Sign in to buy
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
BIOSGN TO2
SE0018588220
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Biosergen AS with ticker BIOSGN TO2
Status
Active
Amount of instruments
8 430 531
Currency
SEK
Trading period
26 Oct 2022 - 22 Aug 2023
Terms
One (1) warrant TO2 entitles the holder to subscribe for one (1) new share for the price which corresponds to seventy (70) percent of the volume-weighted average trading price during the period July 28, 2023, - August 10, 2023, however, not less than share quota value and not more than SEK 4.50 per share.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
BIOSGN
SE0016013460
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Biosergen AS with ticker BIOSGN
Status
Active
Amount of instruments
28 101 775
Currency
SEK
First trading date
24 Jun 2021
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
BIOSGN TO1
SE0016013478
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Biosergen AS with ticker BIOSGN TO1
Status
Archived
Amount of instruments
5 000 000
Currency
SEK
Trading period
24 Jun 2021 - 08 Jun 2022
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for SEK 20.
Update (15.06.2021): Warrants TO1 is scheduled to be listed at Nasdaq First North Growth Market since June 24, 2021.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
BIOSGN TO2
SE0018588220
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Biosergen AS with ticker BIOSGN TO2
Status
Active
Amount of instruments
8 430 531
Currency
SEK
Trading period
26 Oct 2022 - 22 Aug 2023
Terms
One (1) warrant TO2 entitles the holder to subscribe for one (1) new share for the price which corresponds to seventy (70) percent of the volume-weighted average trading price during the period July 28, 2023, - August 10, 2023, however, not less than share quota value and not more than SEK 4.50 per share.
Exercise
Sign in to buy
People
Peder Møller Andersen
CEO
Torsten Rüdiger Goesch
Chairman of the board
Lena Degling
Board member
Achim Kaufhold
Board member
Marianne Kock
Board member
Henrik Moltke
Board member
Hanne Mette Dyrlie Kristensen
Board member
Mattias Klintemar
Board member
Company Details
Sector
HEALTH CARE

Address
Vestre Rosten 81
Zip code
7075
City/district
Trondheim
Country
Norway (NO)
Phones
Registration number
987 622 075
LEI code
549300C2ME54NKQH5J59
First trade date
24 Jun 2021
Registration date
23 Dec 2004
Short name
BIOSGN

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More